OKE is in a sustained uptrend, with the stock up 38.81% over the past year and 25.52% year-to-date, materially outperforming the S&P 500's 15.53% and 11.93% respective gains. At a current price of $93.31, the stock sits at roughly 81.7% of its 52-week range of $64.02 to $99.85 — elevated but not at the highs, implying the stock retains upside room toward resistance while carrying some overextension risk after a strong run. The 23.28 percentage-point relative strength advantage over SPY over 12 months confirms genuine leadership rather than beta-driven drift, especially notable given the stock's low 0.798 beta.

Short-term momentum has decelerated and diverged from the longer-term trend: the 1-month change is just +0.66% and the 3-month change is -0.22%, both trailing SPY's +1.22% and +2.69% over the same windows, producing negative relative strength readings of -0.56 and -2.91. This suggests a consolidation phase or mean-reversion pause within a broader uptrend rather than a trend reversal, particularly since the 6-month change remains a healthy +11.74%. The most recent session showed a sharp +2.93% bounce off the prior close of $90.65 to $93.31 on volume of roughly 2.93 million shares, hinting that buyers are defending the $90 area and that the September pullback to $85.27 may have marked a short-term bottom.

Key technical support rests near the 52-week low of $64.02, with intermediate support around the recent $85-$86 swing lows; resistance sits at the 52-week high of $99.85, and a breakout above that level would signal a fresh leg higher and likely invite momentum buyers. A breakdown below $85 would undermine the uptrend structure and put the $80 area in play. With a beta of 0.798, OKE is roughly 20% less volatile than the market, which supports larger position sizing for risk-adjusted exposure and explains the relatively contained max drawdown of -12.97% despite the mid-year chop.

Revenue is growing at an exceptional clip: Q2 2026 revenue reached $12.05 billion, up 52.77% year-over-year from $7.89 billion in Q2 2025, extending a multi-quarter acceleration from $9.62 billion in Q1 2026 and $9.07 billion in Q4 2025. The growth is heavily driven by liquids commodity sales of $10.38 billion, supplemented by transportation and storage revenue of $816 million and residue natural gas sales of $438 million, reflecting both volume growth and the expanded asset base from acquisitions. This trajectory — reinforced by the Brazos Midland acquisition and raised guidance — supports a durable multi-year growth case, though investors should note that commodity-linked liquids sales introduce revenue volatility even as fee-based contracts stabilize cash flow.

Profitability is solid and improving on an absolute basis: Q2 2026 net income was $966 million (up from $841 million a year earlier) on a 14.15% gross margin and 20.72% operating margin, with net margin at 10.10%. Gross margin has compressed from 26.67% in Q1 2026 and 29.44% in Q4 2025, largely a mix effect from lower-margin commodity liquids sales growing faster than fee-based segments, while EBITDA rose to $1.98 billion from $1.92 billion. The 15.10% ROE and 5.77% ROA are respectable for a capital-intensive midstream operator, and the stable ~10.8% net margin across recent quarters signals earnings consistency despite the margin mix shift.

Balance sheet leverage is the key watch item: debt-to-equity stands at 1.46x, total debt-to-capitalization at 59.0%, and the current ratio is a thin 0.71, indicating reliance on capital markets and revolving facilities for liquidity. Free cash flow is robust at $2.91 billion TTM, with Q2 2026 FCF of $1.44 billion on operating cash flow of $2.05 billion against $613 million of capex, comfortably covering the $674 million quarterly dividend — though the 76.1% payout ratio leaves a modest cushion. Interest coverage of roughly 3.7x and a cash-flow-to-debt ratio near 0.06 reflect the structural leverage typical of midstream, manageable but sensitive to rate and refinancing conditions.